Deutsch
TU Dresden

search

 

 

Prof. Dr. Michael Brand

Director

Prof. Michael Brand
Center for Regenerative Therapies TU Dresden (CRTD)
Fetscherstraße 105
01307 Dresden
Germany
Phone: +49 (0)351 458 82300
michael.brand[at]tu-dresden.de

The Director is a CRTD professor who represents the CRTD both within and outside of the university. He is the chairman of the Advisory Board,  Executive Board, and the Research Group Leader Assembly, and heads the Administration and the CRTD Technology Platform.

Scientific Advisory Board (SAB)

Prof. Dr. Anthony D. HoUniversität Heidelberg, Heidelberg, Germany
Prof. Dr. Jeffrey Hubbell Institute for Molecular Engineering, University of Chicago, USA
Prof. Dr. Reinhold ErbenUniversity of Veterinary Medicine Vienna, Vienna, Austria
Prof. Dr. Kenneth D. PossDuke University, School of Medicine, Durham, USA
Prof. Dr. Charles ffrench-ConstantMRC Centre for Regenerative Medicine (CRM), University of Edinburgh, Edinburgh, UK
Prof. Dr. Botond RoskaFriedrich Miescher Institute, Basel, Switzerland
Prof. Dr. Catherina G. BeckerEdinburgh Medical School, Centre for Neuroregeneration, Edinburgh, UK
Prof. Dr. Maria-Grazia RoncaroloStanford School of Medicine, Stanford, California
Prof. Dr. Lori SusselBarbara Davis Center for Diabetes, University of Colorado

 

 

In 2006, the CRTD was founded as a research centre of the German Research Foundation (DFG FZ 111) and in the same year was awarded the title of Cluster of Excellence (EXC 168) by the Federal Excellence Initiative. In 2012, the CRTD was confirmed as both a DFG Research Centre and a Cluster of Excellence for a further five years. In 2019 the CRTD was taken over by funding by TU Dresden and the Free State of Saxony.

Since the CRTD was founded, our group leaders have raised EUR 75.6 million in third-party funding (including a flat-rate programme fee). This included well-known funding formats such as Collaborative Research Centres (SFBs), Alexander von Humboldt Professors, ERC Starting and ERC Advanced Grants, Freigeist Fellowships, and Emmy Noether Grants.


The Center for Molecular and Cellular Bioengineering (CMCB) was established in 2016 as an umbrella organization for the three institutions BIOTEC, CRTD and B CUBE. These scientifically independent operating institutes work together under the CMCB roof, above all with regard to their strategic development within the university and link teaching, administration, scientific infrastructure and services. The institutes of the CMCB attach great importance to interdisciplinarity, innovation and internationality. They have a lasting influence on the research profile line "Health Sciences, Biomedicine and Bioengineering" of the TU Dresden and have a decisive influence on the activities of the university in the excellence strategy of the federal and state governments.